Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome
© Mégarbané and Mégarbané; licensee BioMed Central Ltd. 2011
Received: 11 December 2010
Accepted: 21 May 2011
Published: 21 May 2011
The IFAP syndrome is a rare X-linked genetic disorder reported in nearly 40 patients. It is characterized by the triad of Ichthyosis Follicularis, Alopecia, and Photophobia from birth. Other features such as short stature, intellectual disability, and seizures may develop in the first few years of life. Skin histopathology is non-specific and consists of dilated hair follicles with keratin plugs extending above the surface of the skin, decreased or absent sebaceous glands, and decreased desmosomes in number and size. The disorder results from mutations in the MBTPS2 gene that impairs cholesterol homeostasis and the ability to cope with endoplasmic reticulum stress. Follicular hyperkeratosis can be treated using topical keratolytics, emollients and urea preparations. A moderate response to acitretin therapy has been noted in some patients. Intensive lubrication of the ocular surface is essential. Life expectancy in patients with IFAP syndrome can vary from death in the neonatal period to normal surviving. Cardiopulmonary complications remain the major cause of death.
Disease name and synonyms
Ichthyosis Follicularis, Atrichia, Photophobia
IFAP syndrome (OMIM 308205) is a rare genetic disorder characterized by ichthyosis and alopecia from birth and sometimes accompanied by short stature, intellectual disability, and seizures that develop in the first few years of life. Photophobia may also be present in the first year of life or appears in infancy or early childhood. Its mode of inheritance is X-linked recessive, thus mostly affecting males. Affected or carrier females may display some of its clinical features.
Review of clinical features associated with IFAP syndrome.
Percentage of male patients
Lack of sebaceous glands
Spiny follicular projections
Ichthyosis follicularis is characterized by widespread non inflammatory thorn-like follicular projections. Dyskeratotic papules are most pronounced over the extensor extremities and scalp and are symmetrically distributed . Congenital alopecia involving the scalp, eyebrows and eyelashes is another essential cutaneous manifestation of IFAP (Figure 1A). A noncicatricial complete body alopecia is also a classical feature. Variable degrees of a collodion membrane may be present in the neonate. Psoriasiform plaques (Figure 1B-C), angular cheilitis, periungueal inflammation, dystrophic nails, hypohidrosis, and atopic eczema can be present. The palms and soles are generally unaffected; one patient had a plantar keratoderma . Affected or carrier females could present milder signs and symptoms such as cutaneous hyperkeratotic lesions that follow the lines of Blaschko, asymmetric distribution of body hair, and/or patchy alopecia, phenotype attributed to lyonisation .
Photophobia is an essential feature for the diagnosis of IFAP (Figure 1A). It can be present early in life or later in childhood. Superficial corneal ulceration and vascularization may lead to progressive corneal scarring and photophobia . Males with IFAP have an inexorable progression of corneal vascularization and loss of vision . Atopic keratoconjunctival inflammation, chronic tearing, cataract, horizontal nystagmus, astigmatism and myopia have been reported as well . Slit lamp examination can show the presence of a diffuse punctate epithelial keratopathy with diffuse vascularizing keratitis and rare areas of partial corneal opacification next to areas with maintained corneal transparency . The anterior chamber, lens and ocular fundus are usually normal.
Affected or carrier females could also present photophobia in the first year of life, and retinal vascular tortuosity .
The most frequent neurological features in IFAP are intellectual disability, and seizures (Table 1). Other findings include olivo-cerebellar atrophy, malformation of the temporal lobes, mild inner cerebral atrophy, and hypoplasia of the corpus callosum [2, 10].
Other clinical features associated with IFAP syndrome consist of short stature, dysmorphic features such as frontal bossing, choanal atresia, and large ears. Intestinal anomalies such as omphalocele, Hirschsprung disease, congenital aganglionic megacolon, stenosis of the small intestine, and inguinal hernia, renal, cardiac and vertebral anomalies, and cleft hands have been reported [14, 17]. Recurrent infections are often noted in IFAP syndrome. External genitalia are almost always normal; few cases presented with cryptorchidism [3, 14, 16, 17], and one with a hypospadias . Dental development is normal.
IFAP syndrome results from missense mutations in the membrane-bound transcription factor protease site 2 (MBTPS2) gene . MBTPS2 is a membrane-embedded zinc metalloprotease that activates signaling proteins involved in sterol control of transcription and endoplasmic reticulum (ER) stress response [25, 26]. It impairs cholesterol homeostasis and the ability to cope with endoplasmic reticulum stress. Functional studies on different mutations showed that patients with mutations that result in the lowest residual MBTPS2 activity had the most severe phenotypes . Nevertheless, no clear phenotype/genotype correlation could be evidenced. Indeed, recently a Japanese patient with IFAP syndrome carrying the c.1286G > A (p.Arg429His) mutation in MBTPS2, was not as severely affected as the patients from a German family carrying the same mutation [16, 17]. Furthermore, it was shown that the p.Asn508Ser mutation causes IFAP syndrome and a close allelic syndrome named "Keratosis follicularis spinulosa decalvans" [17, 27]. Those observations raise the possibility that modifying factors might modulate the phenotype in this syndrome.
The diagnosis of the IFAP syndrome is based on the clinical features and on the presence of a mutation in the MBTPS2 gene.
Skin histopathology is non-specific and consists of dilated hair follicles with keratin plugs extending above the surface of the skin, decreased or absent sebaceous glands and normal sweat glands. Transverse section of scalp biopsy can reveal abortive sebaceous glands in hair follicles . The number of total hair follicles is not significantly decreased suggesting that the pilosebaceous hypoplasia might arise from impaired maturation during hair follicle morphogenesis .
On electron microscopy moderate spongiotic changes associated with partial disruption of the intercellular bridges, decreased desmosomes in number and size, and some dyshesion of the cells could be seen . Examination of the cornea with EM can show reduced number of desmosomes in the corneal epithelium, dispersed bundles of tonofilaments and dilated intercellular gaps with segregated desmosome remnants 
IFAP syndrome cannot be detected prenatally by ultrasonography. If the mutation has been characterized in a carrier mother, prenatal diagnosis can be proposed. No cases of mosaicism have reported so far.
A recessive X-linked pattern of inheritance has been established for IFAP. Therefore, the risk for a female carrier to have an affected son is 50%. The mutation might also arise in the patient de novo.
Recently, a mother and daughter , and 2 unrelated female patients  with an IFAP syndrome were reported. They did not have linear distribution of skin lesions, suggesting an autosomal dominant mode of transmission. Thus, besides X-linked recessive inheritance, an autosomal dominant mode of inheritance could be present.
Major conditions in which ichtyosis and alopecia are both present (14).
Alopecia-Skeletal anomalies-Mental retardation
Ectodermal dysplasia-Alopecia-Mental retardation
Hereditary mucoepithelial dysplasia
Keratosis follicularis spinulosa decalvans
Ichthyosis, alopecia, eclabion, ectropion and mental retardation
The IFAP syndrome and the dermotrichic syndrome have overlapping manifestations. Both are characterized by ichthyotic lesions and atrichia from birth, and short stature, intellectual disability, and seizures. They can be differentiated mainly on the basis of nail, skeletal, and intestinal anomalies, hypohidrosis, and megacolon present in the dermotrichic syndrome and ocular and respiratory disorders in the IFAP syndrome. In fact, overlap between both syndromes had already been noted in few patients [13, 14] showing that both syndromes could be identical.
The HMD is an autosomal dominant condition which can be differentiated from IFAP by the presence of well demarcated erythema of the oral mucosa and a psoriasiform perineal rash, chronic erythematous macules and papules on palate and gingival and recurrent respiratory infections in infancy, cataracts in childhood, and fibrocystic lung disease in adulthood .
KID syndrome shares many features with IFAP. Nevertheless, in patients with KID syndrome nails are often dystrophic, teeth may be small or malformed, and ocular changes are usually observed during the 2nd or 3rd decade. In addition, there is a congenital hearing loss, palmoplantar hyperkeratosis with leather grain-like keratoderma is present but no follicular hyperkeratosis, and the mode of inheritance is autosomal dominant .
KFSD is X-linked recessive and causes follicular hyperkeratosis, hyperkeratosis of the calcaneal regions of the soles, scarring alopecia, absent eyebrows and eyelashes, and a corneal dystrophy with marked photophobia. Carriers may have mild manifestations. KFSD differs from IFAP syndrome in that the alopecia is not congenital and is progressively scarring, and that affected patients have milder phenotype than those with IFAP. Recently, mutations in the MBTPS2 gene were found in KFSD patients indicating that both IFAP and KFSD are within the spectrum of one genetic disorder with overlapping phenotypes .
A moderate response to acitretin therapy at a dose of 0.3 to 1 mg/Kg/day with improvement in cutaneous features and corneal erosions but no changes regarding alopecia and photophobia have been noted in some patients [11, 15]. Otherwise, follicular hyperkeratosis can be treated using topical keratolytics, urea preparations, and emollients. Topical retinoids are not suitable because of their irritation. Corneal vascularization is relentless in affected boys and does not respond to topical corticosteroid therapy. Intensive lubrication of the ocular surface remains the mainstay of therapy . Seizures must be treated accordingly.
Life expectancy in patients with IFAP syndrome can vary from death in the neonatal period to normal surviving. The oldest reported patient was 33 years old . Cardiopulmonary complications were the main cause of death.
Written informed consent was obtained from the patient's parents for publication of this review and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- MacLeod JMH: Three cases of 'ichthyosis follicularis' associated with baldness. Br J Dermatol. 1909, 21: 165-189.Google Scholar
- Bibas-Bonet H, Fauze R, Boente MC, Coronel AM, Asial R: IFAP syndrome "plus" seizures, mental retardation, and callosal hypoplasia. Pediatr Neurol. 2001, 24: 228-231. 10.1016/S0887-8994(00)00261-7.View ArticlePubMedGoogle Scholar
- Boente MC, Bibas-Bonet H, Coronel AM, Asial RA: Atrichia, ichthyosis, follicular hyperkeratosis, chronic candidiasis, keratitis, seizures, mental retardation and inguinal hernia: a severe manifestation of IFAP syndrome?. Eur J Dermatol. 2000, 10: 98-102.PubMedGoogle Scholar
- Cambiaghi S, Barbareschi M, Tadini G: Ichthyosis follicularis with atrichia and photophobia (IFAP) syndrome in two unrelated female patients. J Am Acad Dermatol. 2002, 46: 156-158. 10.1067/mjd.2002.112930.View ArticleGoogle Scholar
- Cursiefen C, Schlotzer-Schrehardt U, Holbach LM, Pfeiffer RA, Naumann GO: Ocular findings in ichthyosis follicularis, atrichia, and photophobia syndrome. Arch Ophthalmol. 1999, 117: 681-684.View ArticlePubMedGoogle Scholar
- Ding YG, Wang JY, Qiao JJ, Mao XH, Cai SQ: A novel mutation in MBTPS2 causes ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome in a Chinese family. Br J Dermatol. 2010, 163: 886-889. 10.1111/j.1365-2133.2010.09890.x.View ArticlePubMedGoogle Scholar
- Eramo LR, Esterly NB, Zieserl EJ, Stock EL, Hermann J: Ichthyosis follicularis with alopecia and photophobia. Arch Dermatol. 1985, 121: 1167-1174. 10.1001/archderm.121.9.1167.View ArticlePubMedGoogle Scholar
- Hamm H, Meinecke P, Traupe H: Further delineation of the ichthyosis follicularis, atrichia, and photophobia syndrome. Eur J Pediatr. 1991, 150: 627-629. 10.1007/BF02072621.View ArticlePubMedGoogle Scholar
- Kamo M, Ohyama M, Kosaki K, Amagai M, Ebihara T, Nakayama J, Ishiko A: Ichthyosis Follicularis, Alopecia, and Photophobia Syndrome: A Case Report and a Pathological Insight Into Pilosebaceous Anomaly. Am J Dermatopathol. 2011, 33: 403-406.View ArticlePubMedGoogle Scholar
- Keyvani K, Paulus W, Traupe H, Kiesewetter F, Cursiefen C, Huk W, Raab K, Orth U, Rauch A, Pfeiffer RA: Ichthyosis follicularis, alopecia and photophobia (IFAP) syndrome: Clinical and neuropathological observations in a 33 year old man. Am J Med Genet. 1998, 78: 371-377. 10.1002/(SICI)1096-8628(19980724)78:4<371::AID-AJMG13>3.0.CO;2-F.View ArticlePubMedGoogle Scholar
- Khandpur S, Bhat R, Ramam M: Ichthyosis follicularis, alopecia and photophobia (IFAP) syndrome treated with acitretin. J Eur Acad Dermatol Venereol. 2005, 19: 759-762. 10.1111/j.1468-3083.2005.01318.x.View ArticlePubMedGoogle Scholar
- Konig A, Happle R: Linear lesions reflecting lyonization in women heterozygous for IFAP syndrome (ichthyosis follicularis with atrichia and photophobia). Am J Med Genet. 1999, 85: 365-368. 10.1002/(SICI)1096-8628(19990806)85:4<365::AID-AJMG12>3.0.CO;2-#.View ArticlePubMedGoogle Scholar
- Martino F, D'Eufemia P, Pergola MS, Finocchiaro R, Celli M, Giampà G, Frontali M, Giardini O: Child with manifestations of dermotrichic syndrome and ichthyosis follicularis-alopecia-photophobia (IFAP) syndrome. Am J Med Genet. 1992, 44: 233-236. 10.1002/ajmg.1320440222.View ArticlePubMedGoogle Scholar
- Mégarbané H, Zablit C, Waked N, Lefranc G, Tomb R, Mégarbané A: Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome: report of a new family with additional features and review. Am J Med Genet. 2004, 124A: 323-327. 10.1002/ajmg.a.20352.View ArticlePubMedGoogle Scholar
- Ming A, Happle R, Grzeschik KH, Fischer G: Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome due to mutation of the gene MBTPS2 in a large Australian kindred. Pediatr Dermatol. 2009, 26: 427-431. 10.1111/j.1525-1470.2009.00946.x.View ArticlePubMedGoogle Scholar
- Nakayama J, Iwasaki N, Shin K, Sato H, Kamo M, Ohyama M, Noguchi E, Arinami T: A Japanese case of ichthyosis follicularis with atrichia and photophobia syndrome with an MBTPS2 mutation. J Hum Genet. 2011, 56: 250-252. 10.1038/jhg.2010.163.View ArticlePubMedGoogle Scholar
- Oeffner F, Fischer G, Happle R, König A, Betz RC, Bornholdt D, Neidel U, Boente Mdel C, Redler S, Romero-Gomez J, Salhi A, Vera-Casaño A, Weirich C, Grzeschik KH: IFAP syndrome is caused by deficiency in MBTPS2, an intramembrane zinc metalloprotease essential for cholesterol homeostasis and ER stress response. Am J Hum Genet. 2009, 84: 459-67. 10.1016/j.ajhg.2009.03.014.PubMed CentralView ArticlePubMedGoogle Scholar
- Rai VM, Shenoi SD: Ichthyosis follicularis with alopecia and photophobia (IFAP) syndrome. Indian J Dermatol Venereol Leprol. 2006, 72: 136-138. 10.4103/0378-6323.25640.View ArticlePubMedGoogle Scholar
- Sato-Matsumura KC, Matsumura T, Kumakiri M, Hosokawa K, Nakamura H, Kobayashi H, Ohkawara A: Ichthyosis follicularis with alopecia and photophobia in a mother and daughter. Br J Dermatol. 2000, 142: 157-162. 10.1046/j.1365-2133.2000.03260.x.View ArticlePubMedGoogle Scholar
- Tang L, Liang J, Wang W, Yu L, Yao Z: A novel mutation in MBTPS2 causes a broad phenotypic spectrum of ichthyosis follicularis, atrichia, and photophobia syndrome in a large Chinese family. J Am Acad Dermatol. 2011, 64: 716-722. 10.1016/j.jaad.2010.02.045.View ArticlePubMedGoogle Scholar
- Tsolia M, Aroni K, Konstantopoulou I, Karpathios T, Tsoukatou T, Paraskevakou H, Stavrinadis C, Fretzayas A: Ichthyosis follicularis with alopecia and photophobia in a girl with cataract: histological and electron microscopy findings. Acta Derm Venereol. 2005, 85: 51-55. 10.1080/00015550410022230.View ArticlePubMedGoogle Scholar
- Zeligman I, Fleisher TL: Ichthyosis follicularis. Arch Dermatol. 1959, 80: 413-420.View ArticlePubMedGoogle Scholar
- Harper J, Oranje A, Prose NS: IFAP syndrome. Text book of pediatric dermatology. Edited by: Wiley-Blackwell. 2 2006, 2: 1348-1349.Google Scholar
- Traboulsi E, Waked N, Mégarbané H, Mégarbané A: Ocular findings in ichthyosis follicularis-alopecia-photophobia (IFAP) syndrome. Ophthalmic Genet. 2004, 25: 153-156. 10.1080/13816810490514405.View ArticlePubMedGoogle Scholar
- Rawson RB, Zelenski NG, Nijhawan D, Ye J, Sakai J, Hasan MT, Chang TY, Brown MS, Goldstein JL: Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol Cell. 1997, 1: 47-57. 10.1016/S1097-2765(00)80006-4.View ArticlePubMedGoogle Scholar
- Zelenski NG, Rawson RB, Brown MS, Goldstein JL: Membrane topology of S2P, a protein required for intramembranous cleavage of sterol regulatory element-binding proteins. J Biol Chem. 1999, 274: 21973-21980. 10.1074/jbc.274.31.21973.View ArticlePubMedGoogle Scholar
- Boralevi F, Haftek M, Vabres P, Lepreux S, Goizet C, Leaute-Labreze C, Taieb A: Hereditary mucoepithelial dysplasia: clinical, ultrastructural and genetic study of eight patients and literature review. Br J Dermatol. 2005, 153: 310-318. 10.1111/j.1365-2133.2005.06664.x.View ArticlePubMedGoogle Scholar
- Freire-Maia N, Pinheiro M: Ectodermal dysplasias: A clinical and genetic study. New York: Alan R Liss, Inc; 1984: 172-173.Google Scholar
- Aten E, Brasz LC, Bornholdt D, Hooijkaas IB, Porteous ME, Sybert VP, Vermeer MH, Vossen RH, van der Wielen MJ, Bakker E, Breuning MH, Grzeschik KH, Oosterwijk JC, den Dunnen JT: Keratosis Follicularis Spinulosa Decalvans is caused by mutations in MBTPS2. Hum Mutat. 2010, 31: 1125-1133. 10.1002/humu.21335.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.